• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清 GP73 - 一种用于 ALT 正常或轻度升高的慢性乙型肝炎病毒感染患者肝脏炎症的额外生化标志物。

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT.

机构信息

Clinical Liver Center, The 910th Hospital of the People's Liberation Army, Quanzhou, 362000, China.

Clinical Liver Center, Decheng hospital of Quanzhou/Affiliated of Huaqiao University, Quanzhou, 362000, China.

出版信息

Sci Rep. 2019 Feb 4;9(1):1170. doi: 10.1038/s41598-018-36480-3.

DOI:10.1038/s41598-018-36480-3
PMID:30718535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6362062/
Abstract

This study aimed to assess the feasibility of GP73 as a diagnostic marker for liver inflammation and fibrosis in chronic HBV patients with normal or slightly raised ALT (<2 ULN) and to develop models based on GP73 and other biochemical parameters to improve diagnostic accuracy. Serum GP73 levels were analyzed in 220 chronic HBV patients with normal or slightly raised ALT who underwent liver biopsy. The results showed that the area under the receiver operating characteristic (ROC) curve (AUC) was 0.806 for predicting significant liver inflammation (≥G2), while it was 0.742 for predicting significant fibrosis (≥S2). These results suggest that GP73 has higher diagnostic value for liver inflammation than liver fibrosis. Combining GP73, AST and ALB, as a diagnostic model for predicting significant liver inflammation, resulted in superior diagnostic performance over GP73 alone (AUC value increased from 0.806 to 0.854, z = 2.299, P = 0.021). By applying this diagnostic model, over 80% of chronic HBV patients with normal or slightly raised ALT will be correctly identified and hence avoid delay in diagnosis and treatment. In conclusion, GP73 would be an additional serum marker for predicting liver inflammation and fibrosis in chronic HBV patients with normal or slightly raised ALT.

摘要

本研究旨在评估 GP73 作为 ALT(<2ULN)正常或轻度升高的慢性乙型肝炎患者肝炎症和纤维化的诊断标志物的可行性,并建立基于 GP73 和其他生化参数的模型以提高诊断准确性。对 220 例 ALT 正常或轻度升高行肝活检的慢性乙型肝炎患者进行血清 GP73 水平分析。结果显示,预测显著肝炎症(≥G2)的受试者工作特征曲线(ROC)下面积(AUC)为 0.806,而预测显著纤维化(≥S2)的 AUC 为 0.742。这些结果表明,GP73 对肝炎症的诊断价值高于肝纤维化。将 GP73 联合 AST 和 ALB 作为预测显著肝炎症的诊断模型,其诊断性能优于单独使用 GP73(AUC 值从 0.806 增加到 0.854,z=2.299,P=0.021)。应用该诊断模型,80%以上 ALT 正常或轻度升高的慢性乙型肝炎患者将被正确识别,从而避免延误诊断和治疗。总之,GP73 可作为预测 ALT 正常或轻度升高的慢性乙型肝炎患者肝炎症和纤维化的附加血清标志物。

相似文献

1
Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT.血清 GP73 - 一种用于 ALT 正常或轻度升高的慢性乙型肝炎病毒感染患者肝脏炎症的额外生化标志物。
Sci Rep. 2019 Feb 4;9(1):1170. doi: 10.1038/s41598-018-36480-3.
2
Predictive value of serum Golgi protein 73 for prominent hepatic necroinflammation in chronic HBV infection.血清高尔基糖蛋白 73 对慢性乙型肝炎病毒感染中明显肝脏坏死性炎症的预测价值。
J Med Virol. 2018 Jun;90(6):1053-1062. doi: 10.1002/jmv.25045. Epub 2018 Feb 20.
3
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.血清高尔基体蛋白73(GP73)是慢性乙型肝炎肝病的诊断和预后标志物。
Medicine (Baltimore). 2015 Mar;94(12):e659. doi: 10.1097/MD.0000000000000659.
4
Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection.评估血清高尔基体蛋白73作为慢性乙型肝炎病毒感染患者显著肝纤维化诊断生物标志物的价值。
J Viral Hepat. 2017 Nov;24 Suppl 1:57-65. doi: 10.1111/jvh.12786.
5
GP73 level in patients with chronic hepatitis B: Relationship with liver biopsy, levels of ALT, AST and HBV DNA.慢性乙型肝炎患者 GP73 水平:与肝活检、ALT、AST 和 HBV DNA 水平的关系。
Indian J Pathol Microbiol. 2022 Jan-Mar;65(1):55-58. doi: 10.4103/IJPM.IJPM_1149_20.
6
Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.血清 GP73,一种用于评估慢性乙型肝炎病毒感染者病情进展的标志物。
PLoS One. 2013;8(2):e53862. doi: 10.1371/journal.pone.0053862. Epub 2013 Feb 13.
7
Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.铜蓝蛋白,慢性乙型肝炎病毒患者纤维化的可靠标志物,这些患者的丙氨酸转氨酶正常或轻度升高。
World J Gastroenterol. 2016 Nov 21;22(43):9586-9594. doi: 10.3748/wjg.v22.i43.9586.
8
Serum liver fibrosis markers discriminate significant liver inflammation in chronic hepatitis B patients with normal or near-normal alanine aminotransferase.血清肝纤维化标志物可区分丙型肝炎患者肝纤维化的严重程度。
J Med Virol. 2019 Apr;91(4):642-649. doi: 10.1002/jmv.25364. Epub 2018 Dec 10.
9
Serum GP73 combined AST and GGT reflects moderate to severe liver inflammation in chronic hepatitis B.血清 GP73 联合 AST 和 GGT 反映慢性乙型肝炎的中重度肝炎症。
Clin Chim Acta. 2019 Jun;493:92-97. doi: 10.1016/j.cca.2019.02.019. Epub 2019 Feb 20.
10
Exploring the Diagnostic Potential of Serum Golgi Protein 73 for Hepatic Necroinflammation and Fibrosis in Chronic HCV Infection with Different Stages of Liver Injuries.探讨血清高尔基糖蛋白 73 在慢性 HCV 感染不同肝损伤阶段对肝坏死炎症和纤维化的诊断潜力。
Dis Markers. 2019 Sep 17;2019:3862024. doi: 10.1155/2019/3862024. eCollection 2019.

引用本文的文献

1
Golgi protein 73 and IL-6 as strong predictors of short-term prognosis in patients with HBV-ACLF.高尔基体蛋白73和白细胞介素-6作为乙型肝炎相关慢加急性肝衰竭患者短期预后的强预测指标。
Sci Rep. 2025 Jul 1;15(1):22191. doi: 10.1038/s41598-025-06472-1.
2
Current Advancements in Serum Protein Biomarkers for Hepatitis B Virus-Associated Hepatocyte Remodeling and Hepatocellular Carcinoma.用于乙肝病毒相关肝细胞重塑和肝细胞癌的血清蛋白生物标志物的当前进展
Immun Inflamm Dis. 2025 Apr;13(4):e70171. doi: 10.1002/iid3.70171.
3
Diagnostic Accuracy of Golgi Protein 73 (GP73) for Liver Fibrosis Staging in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Scoping Review and Cohort Study.

本文引用的文献

1
Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection.高尔基蛋白 73 联合肝硬度检测算法可准确诊断慢性乙型肝炎病毒感染患者的显著肝纤维化。
Liver Int. 2017 Nov;37(11):1612-1621. doi: 10.1111/liv.13536. Epub 2017 Aug 28.
2
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南:乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
3
Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
高尔基体蛋白73(GP73)对代谢功能障碍相关脂肪性肝病肝纤维化分期的诊断准确性:一项范围综述和队列研究
Diagnostics (Basel). 2025 Feb 24;15(5):544. doi: 10.3390/diagnostics15050544.
4
Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study.高尔基体蛋白73:绘制非酒精性脂肪性肝病严重纤维化诊断的新领域:一项前瞻性横断面研究
Front Endocrinol (Lausanne). 2025 Jan 13;15:1506953. doi: 10.3389/fendo.2024.1506953. eCollection 2024.
5
[Not Available].[无可用内容]
Adv Lab Med. 2024 Feb 14;5(2):131-147. doi: 10.1515/almed-2023-0172. eCollection 2024 Jun.
6
Serum biomarkers for liver fibrosis assessment.用于肝纤维化评估的血清生物标志物。
Adv Lab Med. 2023 Nov 14;5(2):115-130. doi: 10.1515/almed-2023-0081. eCollection 2024 Jun.
7
Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients.可溶性程序性细胞死亡蛋白1是预测慢性乙型肝炎患者严重肝脏炎症的一个有前景的生物标志物。
ACS Omega. 2024 Mar 29;9(14):16716-16724. doi: 10.1021/acsomega.4c00780. eCollection 2024 Apr 9.
8
Validation of the novel GLAS algorithm as an aid in the detection of liver fibrosis and cirrhosis based on GP73, LG2m, age, and sex.新型GLAS算法基于GP73、LG2m、年龄和性别辅助检测肝纤维化和肝硬化的验证。
Clin Proteomics. 2023 Nov 28;20(1):53. doi: 10.1186/s12014-023-09444-7.
9
The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data.基于真实世界数据的侵袭性治疗后肝细胞癌血清标志物的预后价值。
J Clin Lab Anal. 2021 Sep;35(9):e23932. doi: 10.1002/jcla.23932. Epub 2021 Aug 17.
10
Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development.慢性病毒性肝炎期间的促纤维化信号与肝癌风险:生物标志物的开发
J Clin Med. 2021 Mar 2;10(5):977. doi: 10.3390/jcm10050977.
白细胞介素17A在脂多糖/D-半乳糖胺诱导的小鼠暴发性肝损伤中起作用。
J Surg Res. 2015 Dec;199(2):487-93. doi: 10.1016/j.jss.2015.05.060. Epub 2015 Jun 4.
4
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.血清高尔基体蛋白73(GP73)是慢性乙型肝炎肝病的诊断和预后标志物。
Medicine (Baltimore). 2015 Mar;94(12):e659. doi: 10.1097/MD.0000000000000659.
5
Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells.上皮特异性ETS(ESE)-1上调了肝癌细胞中GP73的表达。
Cell Biosci. 2014 Dec 8;4(1):76. doi: 10.1186/2045-3701-4-76. eCollection 2014.
6
Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B.慢性乙型肝炎患者血清高尔基体蛋白73水平与肝脏病理分级
Mol Med Rep. 2015 Apr;11(4):2644-52. doi: 10.3892/mmr.2014.3114. Epub 2014 Dec 18.
7
Innate immune responses in hepatitis B virus (HBV) infection.乙型肝炎病毒(HBV)感染中的固有免疫应答。
Virol J. 2014 Feb 7;11:22. doi: 10.1186/1743-422X-11-22.
8
Serum GP73, a marker for evaluating progression in patients with chronic HBV infections.血清 GP73,一种用于评估慢性乙型肝炎病毒感染者病情进展的标志物。
PLoS One. 2013;8(2):e53862. doi: 10.1371/journal.pone.0053862. Epub 2013 Feb 13.
9
Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.白细胞介素 6 和肿瘤坏死因子相关诱导因子在与候选肝癌标志物 GP73 相关的肝脏疾病中升高。
Cancer Biomark. 2012;11(4):161-71. doi: 10.3233/CBM-2012-00276.
10
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.二十年的协议肝活检:有创但对肝移植受者的管理有用。
J Hepatol. 2012 Apr;56(4):840-7. doi: 10.1016/j.jhep.2011.11.016. Epub 2011 Dec 13.